Adenoid cystic carcinoma of the breast: Molecular profiling updates and multidimensional detection of MYB
Pathology - Research and Practice · 2025
DOI: 10.1016/j.prp.2025.156091 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pathology - Research and Practice, 2025. Verfasst von Yingyue Wu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, West China Hospital, Sichuan University, Guoxuexiang 37, Chengdu, Sichuan 610041, China. Hauptthemen laut MEDLINE: Carcinoma, Adenoid Cystic, Breast Neoplasms, Proto-Oncogene Proteins c-myb, Biomarkers, Tumor. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 64 Literaturangaben. Gefördert von: Science and Technology Department of Sichuan Province.
Abstract (Originalsprache)
Adenoid cystic carcinoma (AdCC) of the breast is a rare and distinctive subset of breast cancer that presents significant diagnostic challenges due to its histological diversity and poorly defined molecular traits. AdCC is characterized by the MYB-NFIB fusion, which leads to MYB overexpression and activation of oncogenic downstream pathways, constituting a key disease mechanism. Fluorescence in situ hybridization (FISH) to detect MYB rearrangement has become a critical tool for diagnosing this tumor. However, emerging evidence suggests MYB activation in breast AdCC occurs through multiple mechanisms beyond MYB rearrangements, with several recurrently mutated genes contributing to tumorigenesis. This molecular heterogeneity challenges the diagnostic reliability of FISH-based MYB testing alone. For clinical researchers and practitioners dealing with breast AdCC, a current and thorough understanding of its molecular attributes and diagnostic approaches is essential. This review synthesizes recent advances in breast AdCC molecular genetics, encompassing MYB/MYBL1 rearrangements or amplifications, NOTCH pathway gene mutations, and chromatin remodeling gene alterations. We critically evaluate contemporary methodologies for MYB assessment and discuss their clinical implications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, West China Hospital, Sichuan University, Guoxuexiang 37, Chengdu, Sichuan 610041, China.
- Department of Pathology, West China Hospital, Sichuan University, Guoxuexiang 37, Chengdu, Sichuan 610041, China. Electronic address: 2376049840@qq.com.
Förderung
- Science and Technology Department of Sichuan Province
Zitieren
APA
Wu, Y., Luo, J., Zeng, X., Yu, W., Zhang, Z., & Wei, B. (2025). Adenoid cystic carcinoma of the breast: Molecular profiling updates and multidimensional detection of MYB. Pathology - Research and Practice. https://doi.org/10.1016/j.prp.2025.156091
Vancouver
Wu Y, Luo J, Zeng X, Yu W, Zhang Z, Wei B. Adenoid cystic carcinoma of the breast: Molecular profiling updates and multidimensional detection of MYB. Pathology - Research and Practice. 2025. doi:10.1016/j.prp.2025.156091
BibTeX
@article{Wu2025,
author = {Wu, Yingyue and Luo, Jia and Zeng, Xiangfei and Yu, Wendie and Zhang, Zhang and Wei, Bing},
title = {Adenoid cystic carcinoma of the breast: Molecular profiling updates and multidimensional detection of MYB},
journal = {Pathology - Research and Practice},
year = {2025},
doi = {10.1016/j.prp.2025.156091}
}
EUVIMED